Pharming names Leverne Marsh, Kenneth Lynard interim co-CEOs as Fabrice Chouraqui steps down
PHAR•Pharming Group said Fabrice Chouraqui mutually agreed to step down as CEO and executive director, effective immediately, and appointed Chief Commercial Officer Leverne Marsh and Chief Financial Officer Kenneth Lynard as interim co-CEOs.
1. Leadership change
Pharming Group announced that Fabrice Chouraqui mutually agreed to step down as CEO and executive director, effective immediately. The board appointed Chief Commercial Officer Leverne Marsh and Chief Financial Officer Kenneth Lynard as interim co-CEOs.
